Detalhe da pesquisa
1.
What are economic costs and when should they be used in health economic studies?
Cost Eff Resour Alloc
; 21(1): 31, 2023 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37189118
2.
Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls.
Clin Infect Dis
; 75(1): e962-e973, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35245941
3.
Optimizing Benefits of Testing Key Workers for Infection with SARS-CoV-2: A Mathematical Modeling Analysis.
Clin Infect Dis
; 71(12): 3196-3203, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32634823
4.
Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation.
Value Health
; 23(3): 309-318, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32197726
5.
Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients.
Clin Infect Dis
; 67(5): 693-700, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29529135
6.
Estimating the opportunity costs of bed-days.
Health Econ
; 27(3): 592-605, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29105894
7.
Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region: a mathematical modelling study.
Lancet Reg Health Eur
; 12: 100267, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34870256
8.
Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis.
Lancet Reg Health Eur
; 17: 100381, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35434685
9.
Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis.
Vaccine
; 40(9): 1306-1315, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35109968
10.
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
Lancet Infect Dis
; 21(7): 962-974, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743846
11.
Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region.
medRxiv
; 2021 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282421
12.
RSV immunisation in infants: weighing the options.
Lancet Reg Health Eur
; 38: 100867, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38476744
13.
The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?
Expert Rev Pharmacoecon Outcomes Res
; 18(5): 475-486, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29979895
14.
Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants.
MDM Policy Pract
; 3(1): 2381468317751923, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30288435
15.
Rapid COVID-19 vaccine rollout: immense success but challenges ahead.
Lancet Infect Dis
; 22(3): 302-304, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562376
16.
Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time.
Health Policy
; 112(3): 285-96, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23628483